RxDoctor Payments Data

Zachary Reese, PA

Physician Assistant · Orem, UTNPI 1285395194

Payments from drug & device makers

$3,744in general payments, 2019–2025

Across 208 payments — averaging $18.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$985
  • GSK$258
  • Mylan Specialty L.p.$220
  • Lilly USA, LLC$217
  • Amgen$216
  • Bayer$189
  • plus $2K from 34 others

What the payments were for

  • Food & beverage$3,744100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,744 in reported general payments places this provider in the 90th percentile of 1,543 physician assistant providers in Utah.

See all physician assistant providers in Utah

Medicare billing

Part B allowed, 2024
$60,849
Medicare patients
227
Services billed
2,450

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide43$55,841
TrulicityDulaglutide29$35,793
OzempicSemaglutide30$35,045
EliquisApixaban31$31,812
JardianceEmpagliflozin20$28,625
FarxigaDapagliflozin Propanediol25$28,415
XareltoRivaroxaban15$26,263
LinzessLinaclotide18$13,556
Tresiba Flextouch U-100Insulin Degludec21$12,164
Trelegy ElliptaFluticasone/Umeclidin/Vilanter17$10,702
InvokanaCanagliflozin11$6,709
Omeprazole156$4,105
Lantus SolostarInsulin Glargine,hum.Rec.Anlog28$3,668
Levothyroxine Sodium228$2,554
Gabapentin111$2,278

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$217$91,63572 claims
Novo NordiskOzempic$61$35,04530 claims
Johnson & JohnsonXarelto, Invokana$16$32,97226 claims
PfizerEliquis$115$31,81231 claims
Boehringer IngelheimJardiance$174$28,62520 claims
AstraZenecaFarxiga$129$28,41525 claims
AbbVieLinzess$985$13,55618 claims
GSKTrelegy Ellipta$258$10,70217 claims
Almatica Pharma LLCSertraline Hcl$16$94645 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,543 physician assistant providers in Utah.

Other physician assistant in Orem

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →